Blue Spark Technologies to Present New Standard of Care for Temperature Monitoring at HIMSS 2023

0
168

Blue Spark Technologies, Inc., a leader in wearable remote patient monitoring solutions, will showcase TempTraq® at the HIMSS Global Health Conference & Exhibition at McCormick Place Convention Center in Chicago April 17-21. The company will present several case studies highlighting how continuous temperature monitoring (CTM) is transforming the standard of care in leading hospitals and clinical trials worldwide.

TempTraq is a comfortable, disposable, wireless patch that measures temperature continuously for up to 72 hours. The FDA and CE Cleared Class II medical device monitors temperature remotely in both inpatient and outpatient settings and alerts clinicians to temperature rise events in real time.

“When common complications like sepsis can become life-threatening in less than an hour, monitoring temperature once every four hours–the current standard of care–is not enough,” said John Gannon, president and CEO, Blue Spark Technologies. “Where time is critical, continuous temperature monitoring with TempTraq helps clinicians take immediate action the moment that temperature spikes.”

At the conference, Blue Spark Technologies will also share several studies comparing continuous temperature monitoring with TempTraq to the standard of care:

One study of patients undergoing chemotherapy or stem cell therapy reported that TempTraq detected 89% of fevers earlier.

In another study, of 23 temperature rise events, 21 were detected a median of 140.1 minutes sooner with TempTraq.

The presentation, “TempTraq, Changing the Standard of Care With Remote Continuous Patient Temperature Monitoring,” will take place Wednesday, April 19 at 12:15–12:35 p.m. Central time at the Innovation Hub, Booths 6009-6034 in Hall B, Level 3, North Building. More information is available here.

Blue Spark Technologies will also be performing live product demonstrations during exhibition hours at Booth 6009-04 in the Innovation Hub. More information is available here.